首页> 美国卫生研究院文献>PLoS Clinical Trials >Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China
【2h】

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China

机译:上海市三所医院血液感染大肠埃希菌的抗药性和分子流行病学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Escherichia coli (E. coli) is one of the most frequent and lethal causes of bloodstream infections (BSIs). We carried out a retrospective multicenter study on antimicrobial resistance and phylogenetic background of clinical E. coli isolates recovered from bloodstream in three hospitals in Shanghai. E. coli isolates causing BSIs were consecutively collected between Sept 2013 and Sept 2014. Ninety isolates randomly selected (30 from each hospital) were enrolled in the study. Antimicrobial susceptibility testing was performed by disk diffusion. PCR was used to detect antimicrobial resistance genes coding for β-lactamases (TEM, CTX-M, OXA, etc.), carbapenemases (IMP, VIM, KPC, NDM-1 and OXA-48), and phylogenetic groups. eBURST was applied for analysis of multi-locus sequence typing (MLST). The resistance rates for penicillins, second-generation cephalosporins, fluoroquinolone and tetracyclines were high (>60%). Sixty-one of the 90 (67.8%) strains enrolled produced ESBLs and no carbapenemases were found. Molecular analysis showed that CTX-M-15 (25/61), CTX-M-14 (18/61) and CTX-M-55 (9/61) were the most common ESBLs. Phylogenetic group B2 predominated (43.3%) and exhibited the highest rates of ESBLs production. ST131 (20/90) was the most common sequence type and almost assigned to phylogenetic group B2 (19/20). The following sequence types were ST405 (8/90) and ST69 (5/90). Among 61 ESBL-producers isolates, B2 (26, 42.6%) and ST131 (18, 29.5%) were also the most common phylogenetic group and sequence type. Genetic diversity showed no evidence suggesting a spread of these antimicrobial resistant isolates in the three hospitals. In order to provide more comprehensive and reliable epidemiological information for preventing further dissemination, well-designed and continuous surveillance with more hospitals participating was important.
机译:大肠杆菌(E. coli)是最常见的致死性血液感染(BSI)之一。我们在上海的三家医院对从血液中回收的临床大肠杆菌分离株的抗菌素耐药性和系统发育背景进行了回顾性多中心研究。在2013年9月至2014年9月之间连续收集了引起BSI的大肠杆菌分离株。该研究随机抽取了90株分离株(每家医院30株)。通过纸片扩散进行抗菌药敏试验。 PCR用于检测编码β-内酰胺酶(TEM,CTX-M,OXA等),碳青霉烯酶(IMP,VIM,KPC,NDM-1和OXA-48)和系统发生群的抗药性基因。 eBURST用于分析多基因座序列类型(MLST)。青霉素,第二代头孢菌素,氟喹诺酮和四环素的耐药率很高(> 60%)。登记的90个菌株中有61个(67.8%)产生了ESBL,未发现碳青霉烯酶。分子分析表明,CTX-M-15(25/61),CTX-M-14(18/61)和CTX-M-55(9/61)是最常见的ESBL。系统发育B2组占主导地位(43.3%),并显示出最高的ESBLs产生率。 ST131(20/90)是最常见的序列类型,几乎属于系统进化组B2(19/20)。以下序列类型为ST405(8/90)和ST69(5/90)。在61个ESBL生产者分离株中,B2(26.6%,42.6%)和ST131(18%,29.5%)也是最常见的系统发生群和序列类型。遗传多样性表明没有证据表明这些抗药性耐药菌在三所医院中传播。为了提供更全面和可靠的流行病学信息以防止进一步传播,重要的是要有更多医院参与的精心设计和持续监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号